Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.24 Delayed Data As of May 25 |  +0.06 / +2.74%Today’s Change | 1.93 Today|||52-Week Range 6.50 | -42.42% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $361.4M |
Company Description
Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
Contact Information
Arbutus Biopharma Corp. 701 Veterans Circle Warminster Pennsylvania 18974 |
Employees
Shareholders
| Other institutional | 19.26% |
| Individual stakeholders | 13.36% |
| Mutual fund holders | 10.26% |
Top Executives
| William H. Collier | President, Chief Executive Officer & Director |
| David C. Hastings | Chief Financial & Accounting Officer |
| Michael J. Sofia | Chief Scientific Officer |
| Elizabeth Howard | Secretary, Chief Compliance Officer & EVP |
| Michael J. McElhaugh | Chief Business Officer |
